Skip to main content
Frederick Hayden, MD, Infectious Disease, Charlottesville, VA

FrederickG.HaydenMD

Infectious Disease Charlottesville, VA

Professor Emeritus, Department of Medicine, University of Virginia School of Medicine

Dr. Hayden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hayden's full profile

Already have an account?

  • Office

    345 Crispell Drive, MR-6
    Charlottesville, VA 22908
    Phone+1 434-924-5059

Education & Training

  • University of Rochester Medical Center
    University of Rochester Medical CenterFellowship, Infectious Disease, 1976 - 1978
  • University of Rochester Medical Center
    University of Rochester Medical CenterResidency, Internal Medicine, 1973 - 1976
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1973

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1978 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1992

Publications & Presentations

PubMed

Journal Articles

  • A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19  
    Frederick Hayden, MD, The New England Journal of Medicine
  • Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents  
    Frederick Hayden, MD, The New England Journal of Medicine

Authored Content

  • Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory SyndromeOctober 2020

Press Mentions

  • Japanese Drug Shows Promise in Preventing COVID-19 Infection
    Japanese Drug Shows Promise in Preventing COVID-19 InfectionMarch 24th, 2025
  • Ensitrelvir Effectively Prevents Spread of COVID-19 in Households
    Ensitrelvir Effectively Prevents Spread of COVID-19 in HouseholdsMarch 20th, 2025
  • Ensitrelvir Effectively Prevents Spread of COVID-19 in Households
    Ensitrelvir Effectively Prevents Spread of COVID-19 in HouseholdsMarch 20th, 2025
  • Join now to see all

Grant Support

  • Intravenous Zanamir In Experimental InfluenzaNational Center For Research Resources1998–1999
  • Rimantadine In Treating Influenza A Virus In Adult PatientsNational Center For Research Resources1989
  • Prophylactic Efficacy Of Interferon-Beta 17 Serine In Naturally Acquired ColdsNational Center For Research Resources1988–1989
  • Multiple Dose Pharmacokinetics Of Rimantadine In Older VolunteersNational Center For Research Resources1987–1988